| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO | EVP and CFO | EVP, Americas +4 more
2 companies
Jerome J. Dorlack is President and CEO at ADNT and has filed Form 4s across 2 companies. Jerome J. Dorlack's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $12.4M at current prices.
Historically, Jerome J. Dorlack's trades have earned a middling insider score of 65/100 across 6 rated trades. Over a 12-month horizon, 83.3% of those trades were profitable, with an average 12-month return of +18.5%.
The biggest single holding is ADNT (~$10.7M) as President and CEO. The ADNT filings lean toward selling, a net 51,384 shares.
Jerome J. Dorlack has 44 Form 4 filings on record from February 2017 to February 2026, across 2 companies: President and CEO at Adient (ADNT), 2019–2026; SVP & President Eds at Aptiv (APTV), 2017–2018.
The 70 reported transactions were 30 tax withholdings, 24 stock awards, 7 option or other derivative awards and 6 open-market sales, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $35K and 6 sales worth about $1.9M.
The only open-market purchase was 2,700 shares of ADNT at an average $13.11 on March 13, 2020, about $35K.
The largest open-market sale was 17,884 shares of ADNT at an average $35.38 on December 15, 2023, about $633K. Twelve months later ADNT was down 46%.
1 of the 2 sales since April 2023 was made under a Rule 10b5-1 trading plan; the other was not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2025 | ADNT Adient Plc | President and CEO | Sell | 12,000 | $22.77 | $273,240.00 | -2.6% | -12.1% | -14.6% | |
| Dec 15, 2023 | ADNT Adient Plc | EVP and CFO | Sell10b5-1 | 17,884 | $35.38 | $632,735.92 | -9.0% | -7.6% | -46.1% | |
| Nov 23, 2022 | ADNT Adient Plc | EVP, Americas | Sell | 4,300 | $39.09 | $168,087.00 | -3.0% | +10.1% | -17.3% | |
| May 10, 2022 | ADNT Adient Plc | EVP, Americas | Sell | 7,600 | $31.29 | $237,782.72 | -6.3% | +9.3% | +13.0% | |
| Nov 12, 2021 | ADNT Adient Plc | EVP, Americas | Sell | 7,800 | $46.95 | $366,202.98 | -6.6% | -0.6% | -14.4% | |
| May 20, 2021 | ADNT Adient Plc | EVP, Americas | Sell | 4,500 | $46.58 | $209,611.35 | -3.7% | -14.4% | -31.8% | |
| Mar 13, 2020 | ADNT Adient Plc | VP, Americas | Buy | 2,700 | $13.11 | $35,397.00 | +3.0% | - | - |